Dr Elizabeth Hamlyn

Consultant Physician

Year Qualified: 1998
Qualifications: MBChB, MRCP, MD, DTMH, DFSRH, Diploma in HIV medicine, Diploma in Genitourinary Medicine
Specialty: Sexual Health and HIV Medicine

Special Interests

Adolescent HIV infection
Primary HIV infection
Sexual health in young people

Biography

Consultant physician with responsibility for HIV inpatients and outpatients, including adolescents and young people with HIV infection and transition services from paediatric care. Safeguarding lead within the sexual health department. Special interests include sexual health in young people and Primary HIV infection.

Related services

Research

Ball C, Sudhanva M, Jarosz J, Post FA, Hamlyn E (2016) ‘Is there a role for maraviroc to treat HIV-associated central nervous system white matter disease?‘, AIDS (London, England), 30,(2):334-6
Hurst J, Hoffmann M, Pace M, Williams JP, Thornhill J, Hamlyn E, Meyerowitz J, Willberg C, Koelsch KK, Robinson N, Brown H, Fisher M, Kinloch S, Cooper DA, Schechter M, Tambussi G, Fidler S, Babiker A, Weber J, Kelleher AD, Phillips RE, Frater J (2015) ‘Immunological biomarkers predict HIV-1 viral rebound after treatment interruption‘, Nature communications, 6,():8495
Hamlyn E, Stöhr W, Cooper DA, Fisher M, Tambussi G, Schechter M, Miro JM, Vanobberghen F, Babiker A, Weber J, Mcclure M, Porter K, Fidler S, SPARTAC Investigators. (2015) ‘The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels‘, AIDS (London, England), 29,(11):1355-61
Hamlyn E, Fidler S, Stöhr W, Cooper DA, Tambussi G, Schechter M, Miro JM, Mcclure M, Weber J, Babiker A, Porter K, SPARTAC Trial Investigators. (2014) ‘Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression‘, AIDS (London, England), 28,(6):869-74
Hamlyn E, Ewings FM, Porter K, Cooper DA, Tambussi G, Schechter M, Pedersen C, Okulicz JF, McClure M, Babiker A, Weber J, Fidler S, INSIGHT SMART and SPARTAC Investigators (2012) ‘Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection‘, PloS one, 7,(8):e43754
Hamlyn E, Hickling S, Porter K, Frater J, Phillips R, Robinson M, Mackie NE, Kaye S, McClure M, Fidler S, SPARTAC Investigators (2012) ‘Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection‘, AIDS (London, England), 26,(7):887-90
Hamlyn E, Jones V, Porter K, Fidler S (2010) ‘Antiretroviral treatment of primary HIV infection to reduce onward transmission‘, Current opinion in HIV and AIDS, 5,(4):283-90
Hamlyn E, Welz T, Rebaudengo S, Simms H, Poulton M (2009) ‘Sexual behaviour, condom use and rates of sexually transmitted infections in HIV clinic attendees in South East London‘, International journal of STD & AIDS, 20,(11):757-60
Hamlyn E, Ibrahim MA, Post FA (2008) ‘Resolution of HIV-associated adult lymphocytic interstitial pneumonitis in pregnancy‘, AIDS (London, England), 22,(10):1244-5
Hamlyn E, Easterbrook P (2007) ‘Occupational exposure to HIV and the use of post-exposure prophylaxis‘, Occupational medicine (Oxford, England), 57,(5):329-36
Hamlyn E, Peer A, Easterbrook P (2007) ‘Sexual health and HIV in travellers and expatriates‘, Occupational medicine (Oxford, England), 57,(5):313-21
Hamlyn E, Barrett S, Kelsey J, Lockyer S, Welz T, Poulton M (2007) ‘Improvement in screening for sexually transmitted infections in HIV-positive patients following implementation of a nurse-led clinic‘, International journal of STD & AIDS, 18,(6):424-6
Hamlyn E, Childs K, Post FA (2007) ‘Reducing tuberculosis incidence in HIV-infected patients by tuberculin skin testing, preventive treatment, and antiretroviral therapy‘, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44,(10):1393-4; author reply 1394-5
Hamlyn E, McAllister J, Winston A, Sinclair B, Amin J, Carr A, Cooper DA (2006) ‘Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile?‘, Sexually transmitted infections, 82,(1):21-3